Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lees

Showing results (261-270 of 1,327) with videos related to

Pageof 133
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Prostaglandin E2 in the pathogenesis of pyrogen fever: validation of an intermediary roleF Coceani, I Bishai, J Lees, et al.
Neurology|July 1, 1997
Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET studyN Turjanski, A J Lees, D J Brooks
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1987
Mesulergine and pergolide in previously untreated Parkinson's diseaseA Wright, A J Lees, G M Stern
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2010
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?David A Gallagher, Andrew J Lees, Anette Schrag
Journal of Parkinson'S Disease|June 23, 2019
Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson's DiseaseAngeliki Zarkali, Andrew J Lees, Rimona S Weil
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1984
Remission in spasmodic torticollisD Jayne, A J Lees, G M Stern
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Effects of pyrogens on prostaglandin E2 and thromboxane A2 synthesis in brain: implications for the pathogenesis of feverF Coceani, I Bishai, J Lees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin YahrAndrew J Lees, Eduardo Tolosa, C Warren Olanow
Neurology|April 2, 1999
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studiesN Turjanski, A J Lees, D J Brooks
Lancet (London, England)|January 1, 1979
Neurosyphilis todayL Luxon, A J Lees, R J Greenwood
Pageof 133

Showing results (261-270 of 1,327) with videos related to

Sort By:
Pageof 133
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
Prostaglandin E2 in the pathogenesis of pyrogen fever: validation of an intermediary roleF Coceani, I Bishai, J Lees, et al.
Neurology|July 1, 1997
Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET studyN Turjanski, A J Lees, D J Brooks
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1987
Mesulergine and pergolide in previously untreated Parkinson's diseaseA Wright, A J Lees, G M Stern
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2010
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?David A Gallagher, Andrew J Lees, Anette Schrag
Journal of Parkinson'S Disease|June 23, 2019
Flickering Stimuli Do Not Reliably Induce Visual Hallucinations in Parkinson's DiseaseAngeliki Zarkali, Andrew J Lees, Rimona S Weil
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1984
Remission in spasmodic torticollisD Jayne, A J Lees, G M Stern
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Effects of pyrogens on prostaglandin E2 and thromboxane A2 synthesis in brain: implications for the pathogenesis of feverF Coceani, I Bishai, J Lees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin YahrAndrew J Lees, Eduardo Tolosa, C Warren Olanow
Neurology|April 2, 1999
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studiesN Turjanski, A J Lees, D J Brooks
Lancet (London, England)|January 1, 1979
Neurosyphilis todayL Luxon, A J Lees, R J Greenwood
Pageof 133